- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05912907
Potassium Nitrate in Polycarboxylate as a Direct Pulp Capping
June 11, 2023 updated by: Ahmad Elheeny, Minia University
Potassium Nitrate in Polycarboxylate Versus Mineral Trioxide Aggregate as a Direct Pulp Capping in Young Permanent Molars
The study aimed to compare potassium nitrate in polycarboxylate cement to mineral trioxide aggregate as a direct pulp capping material of young permanent teeth in patients from 7 to 10 ears
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
126
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Al Minya, Egypt, 61111
- Minia university
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 7-10 years of children
- Healthy children classified as ASA I or II
- Asymptomatic vital immature mandibular first molar with extensive and deep caries
- Signs and symptoms of reversible pulpitis
Exclusion Criteria:
- Necrotic teeth or teeth with irreversible pulpitis
- Medically compromised children
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: potassium nitrate in polycarboxilate cement
|
5% potassium nitrate in polycarboxylate; pre-weighed 95 mg zinc oxide powder and 5mg of KNO3 will be placed on a glass slab followed by mixing by polyacrylic acid (liquid) in a 1:1 P/L ratio
|
|
Active Comparator: Mineral Trioxide Aggregate
|
5% potassium nitrate in polycarboxylate; pre-weighed 95 mg zinc oxide powder and 5mg of KNO3 will be placed on a glass slab followed by mixing by polyacrylic acid (liquid) in a 1:1 P/L ratio
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
clinical success rate
Time Frame: 24 months
|
Absence of pain, sensitivity to percussion, fistula or sinus tract, mobility
|
24 months
|
|
Radiographic success rate
Time Frame: 24 months
|
Absence of periapical radiolucency, internal root resorption, external root resorption
|
24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2022
Primary Completion (Estimated)
July 1, 2024
Study Completion (Estimated)
July 1, 2024
Study Registration Dates
First Submitted
June 11, 2023
First Submitted That Met QC Criteria
June 11, 2023
First Posted (Actual)
June 22, 2023
Study Record Updates
Last Update Posted (Actual)
June 22, 2023
Last Update Submitted That Met QC Criteria
June 11, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 532
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulp Disease, Dental
-
Ataturk UniversityHealth Institutes of TurkeyActive, not recruitingPulpitis | Pulp Disease, Dental | Pulpitis - Irreversible | Pulp Exposure, Dental | Pulp Caping | Pulpal InflammationTurkey (Türkiye)
-
Hacettepe UniversityRecruitingPulp Disease, Dental | Dental Caries Extending to PulpTurkey
-
University of SulaimaniCompletedPulp Disease, Dental | Pulp MummificationIraq
-
Ain Shams UniversityCompletedPulp Disease, DentalEgypt
-
Cairo UniversityNational Research Centre, EgyptNot yet recruitingPulp Disease, Dental | Pulpotomy | Vital Pulp Therapies | Pulpotomies Primary Teeth | Pulp TherapyEgypt
-
Cairo UniversityNot yet recruiting
-
McGill University Health Centre/Research Institute...Not yet recruitingPulp Disease, Dental
-
Minia UniversityNot yet recruiting
-
British University In EgyptAin Shams UniversityRecruiting
-
Cairo UniversityCompletedDental Pulp Necrosis | Dental Pulp Disease | Dental Pulp; DegenerationEgypt
Clinical Trials on potassium nitrate in polycarboxilate cement
-
Cairo UniversityUnknownPulpotomy of Immature Lower First Molar(Apexegenesis)
-
Cairo UniversityNational Research Centre, EgyptNot yet recruitingPulp Disease, Dental | Pulpotomy | Vital Pulp Therapies | Pulpotomies Primary Teeth | Pulp TherapyEgypt
-
Washington University School of MedicineRecruitingHeart FailureUnited States
-
University of PennsylvaniaCompleted
-
Queen Mary University of LondonRecruitingHealthy Volunteers | Vascular Function | Nitric OxideUnited Kingdom
-
University of Modena and Reggio EmiliaUniversity of Pavia; University of GenovaCompleted
-
University of PennsylvaniaNorthwestern UniversityCompleted
-
University of PennsylvaniaCompletedHeart Failure | Diastolic Heart FailureUnited States
-
Washington University School of MedicineCompletedHeart FailureUnited States
-
GlaxoSmithKlineCompletedDentine HypersensitivityUnited States